Dry Powder Inhalers: From Bench to Bedside.

J Aerosol Med Pulm Drug Deliv

Department of Pharmacology and Clinical Pharmacy, University of Tripoli, Libya.

Published: December 2023

Dry powder inhalers (DPIs) are now widely prescribed and preferred by the majority of patients. These devices have many advantages over the traditional pressurized metered-dose inhaler (pMDI) but they do have disadvantages. The characteristics of the dose emitted from a DPI are affected by the inhalation manoeuvre used by a patient. Each patient is different and the severity of their lung disease varies from mild to very severe. This affects how they use an inhaler and so determines the type of dose they inhale. An understanding of the pharmaceutical science related to DPIs is important to appreciate the relevance of how patients inhale through these devices. Also, each type of DPI has its unique dose preparation routine, and thus it is essential to follow these recommended steps because errors at this stage may result in no dose being inhaled. All issues related to the inhalation manoeuvre and dose preparation are addressed in this chapter. The importance of the inhalation technique is highlighted with a realization of inhale technique training and checking. During routine patient management, devices should not be switched nor doses increased unless the patient has demonstrated that they can and do use their DPI.

Download full-text PDF

Source
http://dx.doi.org/10.1089/jamp.2023.29103.hcDOI Listing

Publication Analysis

Top Keywords

dry powder
8
powder inhalers
8
inhalation manoeuvre
8
dose preparation
8
dose
5
inhalers bench
4
bench bedside
4
bedside dry
4
inhalers dpis
4
dpis prescribed
4

Similar Publications

Laboratory-scale spray drying can be a useful tool in developing new dry powder formulations for the delivery of biologics such as therapeutic proteins or vaccines. Low-temperature drying is often used in these processes to prevent the exposure of biologics to harsh conditions that could potentially lead to degradation or instability of the final product. However, low-temperature drying on small-scale equipment can result in very low production rates that may not be practical for generating sufficient material for studies requiring larger sample quantities, such as key preclinical or toxicology studies.

View Article and Find Full Text PDF

The efficient removal of CO from exhaust streams and even directly from air is necessary to forestall climate change, lending urgency to the search for new materials that can rapidly capture CO at high capacity. The recent discovery that diamine-appended metal-organic frameworks can exhibit cooperative CO uptake via the formation of ammonium carbamate chains begs the question of whether simple organic polyamine molecules could be designed to achieve a similar switch-like behavior with even higher separation capacities. Here, we present a solid molecular triamine, 1,3,5-tris(aminomethyl)benzene (TriH), that rapidly captures large quantities of CO upon exposure to humid air to form the porous, crystalline, ammonium carbamate network solid TriH(CO)·HO (TriHCO).

View Article and Find Full Text PDF

An investigation was conducted to assess the efficacy of a novel antioxidant supplementation, Transcare, in alleviating transportation-induced stress among Bannur sheep. Thirty female Bannur sheep of 10-12 months, were selected and randomly assigned to two groups: Bannur Non-supplemented (BNS) (n = 15) and Bannur Supplemented (BS) (n = 15). The BS was supplemented with antioxidant powder (Transcare) orally at a dose of 10 g/animal, dissolved in 10 mL drinking water, 45-60 min preload.

View Article and Find Full Text PDF

The EFSA Panel on Food Additive and Flavourings (FAF Panel) provides a scientific opinion on the safety assessment of the proposed use of pea fibre concentrate (FIPEA) as a food additive. FIPEA is a powder consisting mainly of dietary fibres (i.e.

View Article and Find Full Text PDF

Background: Optimal fixed-dose combination (FDC) dual bronchodilators for chronic obstructive pulmonary disease (COPD) are yet to be identified. We aimed to compare outcomes between two types of optimal once-daily FDC dual bronchodilators delivered by a dry powder inhaler (DPI) and soft mist inhaler (SMI).

Methods: Using the Japanese Diagnosis Procedure Combination database, we identified patients with COPD, aged ≥40 years, who were prescribed DPIs or SMIs at discharge from 2015 to 2021.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!